文献速递烧伤创面修复

消退素D2限制大鼠烧伤后二次组织坏死

Resolvin D2 Limits Secondary Tissue Necrosis After Burn Wounds in Rats.
PubMed 文献 · J Burn Care Res · 2018-01-01

本研究在大鼠梳状烫伤模型中,比较静脉注射消退素D2(RvD2)与DNase对二次烧伤坏死的影响。结果显示RvD2治疗组未烧伤间隔区得以保留且血流更高,而对照组烧伤区扩展至间隔区并在伤后7天融合。RvD2组单核细胞与中性粒细胞比值高于DNase组和对照组(P < .05)。

要点

  • RvD2可抑制烧伤后二次坏死并启动再生。
  • RvD2治疗组间隔区保留且血流高于对照组。
  • 炎症消退可能是烧伤治疗的新靶点。

核心结论

  • RvD2抑制二次坏死并启动再生,提示炎症消退可作为烧伤治疗的潜在靶点。

研究设计与样本

  • 雄性Wistar大鼠使用沸水加热的四齿铜梳烫伤,形成2排4个矩形烧伤区及3个未烧伤间隔区。
  • 伤后2小时起,大鼠接受RvD2 25 ng/kg静脉注射每日1次共7天,或DNase 200 U/kg每12小时1次共3天。
  • 采用数码摄影记录坏死、激光多普勒评估总血流、光学相干断层扫描血管成像评估间隔区毛细血管网功能,伤后14天取组织行组织学检查。

主要发现

  • RvD2治疗组间隔区保留且血流更高;对照组烧伤区扩展至间隔区并在伤后7天融合。
  • RvD2组单核细胞与中性粒细胞比值高于DNase组和对照组(P < .05)。

临床怎么用

  • RvD2可能作为限制烧伤后二次坏死、促进再生的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Secondary burn necrosis is the expansion and deepening of the original burn injury several days after injury. Limiting the extent of secondary burn necrosis may improve outcomes. In this study, we examined the ability of the lipid mediator of inflammation-resolution resolvin D2 (RvD2) and chromatin-lysing enzyme (DNase) to reduce secondary burn necrosis. Male Wistar rats were injured using a brass comb with 4 prongs heated in boiling water. This method created 2 parallel rows of 4 rectangular burned areas separated by 3 unburned interspaces. Starting at 2 hours after the burn injury, rats received either 25 ng/kg RvD2 intravenously daily for 7 days or 200 U/kg DNase every 12 hours for 3 days. We documented the necrosis around the initial wounds by digital photography. We used laser Doppler to assess the total blood flux in the burn area. We evaluated the functionality of the capillary network in the interspaces by optical coherence tomography angiography. We performed histological examination of wound skin tissue samples collected at 14 days postburn. We found that the interspace areas were preserved and had higher blood flow in the RvD2-treated group, while the burn areas expanded into the interspace areas, which were confluent by 7 days postburn, in the control-untreated group. We found a larger monocyte-to-neutrophil ratio in the RvD2-treated group compared with the DNase-treated and control groups (P < .05). Overall, RvD2 suppresses secondary necrosis and starts regeneration, highlighting the role of inflammation resolution as a potential therapeutic target in burn care.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Inoue Y, Liu YM, Otawara M, et al. Resolvin D2 Limits Secondary Tissue Necrosis After Burn Wounds in Rats. J Burn Care Res. 2018. PMID: 28877131. doi:10.1097/BCR.0000000000000617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。